Related references
Note: Only part of the references are listed.Induction and transmission of oncogene-induced senescence
Nattaphong Rattanavirotkul et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Intraarterial delivery of virotherapy for glioblastoma
Visish M. Srinivasan et al.
NEUROSURGICAL FOCUS (2021)
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Hong-My Nguyen et al.
ONCOLYTIC VIROTHERAPY (2021)
The Anticancer Potential of T Cell Receptor-Engineered T Cells
Matyas Ecsedi et al.
TRENDS IN CANCER (2021)
Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
Eilam Yeini et al.
ADVANCED THERAPEUTICS (2021)
Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas
Shaochen Fan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks
Hernando Lopez-Bertoni et al.
CANCER RESEARCH (2020)
Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma
Bingtao Tang et al.
CLINICAL CANCER RESEARCH (2020)
Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma
Malte Mohme et al.
CLINICAL CANCER RESEARCH (2020)
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Scott Bang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression
Sabine Galland et al.
JOURNAL OF PATHOLOGY (2020)
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
Vildan B. Cetintas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
CAR T cells: continuation in a revolution of immunotherapy
Anurag K Singh et al.
LANCET ONCOLOGY (2020)
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
David Ruano et al.
MOLECULAR THERAPY (2020)
Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
Lidia Franco-Luzón et al.
Oncotarget (2020)
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Khaphetsi Joseph Mahasa et al.
SCIENTIFIC REPORTS (2020)
Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication
Meysam Mosallaei et al.
CANCER GENE THERAPY (2020)
Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses
Agata Hadrys et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
Chiara Ferraris et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
Yong Luo et al.
ONCOIMMUNOLOGY (2020)
Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses
Christianne Groeneveldt et al.
TRENDS IN IMMUNOLOGY (2020)
Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells
Ivan Trus et al.
VIRUSES-BASEL (2020)
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang et al.
MOLECULAR BIOLOGY REPORTS (2020)
IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
Andreas A. Hombach et al.
CELLS (2020)
Strategies for enhancing intratumoral spread of oncolytic adenoviruses
Nasser Hashemi Goradel et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Targeting telomerase for cancer therapy
Adam N. Guterres et al.
ONCOGENE (2020)
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
María Ochoa de Olza et al.
LANCET ONCOLOGY (2020)
TGF-β suppresses type 2 immunity to cancer
Ming Liu et al.
NATURE (2020)
Cancer immunotherapy via targeted TGF-β signalling blockade in THcells
Shun Li et al.
NATURE (2020)
microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis
Tayebeh Rezaei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Advances in drug delivery technology for the treatment of glioblastoma multiforme
Gi Doo Cha et al.
JOURNAL OF CONTROLLED RELEASE (2020)
p53: 800 million years of evolution and 40 years of discovery
Arnold J. Levine
NATURE REVIEWS CANCER (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
Glioblastoma Stem cells: Driving Resilience through Chaos
Briana C. Prager et al.
TRENDS IN CANCER (2020)
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy
Filippo Rossignoli et al.
CANCER GENE THERAPY (2019)
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma et al.
CANCER CELL (2019)
Viral oncolytic immunotherapy in the war on cancer: Infection control considerations
Elizabeth V. Robilotti et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial
Jobst Christian von Einem et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
Sakhawat Ali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a
Xin Li et al.
STEM CELLS INTERNATIONAL (2019)
The relation between PI3K/AKT signalling pathway and cancer
Saeed Noorolyai et al.
GENE (2019)
Detection and Correlation of Single and Concomitant TP53, PTEN, and CDKN2A Alterations in Gliomas
Igor Andrade Pessoa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWPI inhibitory pathway
Yu-Ru Lee et al.
SCIENCE (2019)
Menstrual Blood-Derived Stem Cells as Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer
Yang Guo et al.
STEM CELLS AND DEVELOPMENT (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration
Youjin Na et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Targeting mutant p53 in cancer: the latest insights
Silvia Di Agostino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
Ali Sakhawat et al.
SCIENTIFIC REPORTS (2019)
Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
Tahir Muhammad et al.
STEM CELL RESEARCH & THERAPY (2019)
Concise Review: Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells
Ilenia Mastrolia et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
Timothy T. Spear et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status
Yuhui Zhang et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Maura C. O'Leary et al.
CLINICAL CANCER RESEARCH (2019)
YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway
Hui Tong et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine
Lijun Chen et al.
STEM CELL RESEARCH & THERAPY (2019)
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Juri Kiyokawa et al.
ONCOLYTIC VIROTHERAPY (2019)
Programming hMSCs into Potential Genetic Therapy in Cancer
Nedime Serakinci et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2019)
Current Prospects of Molecular Therapeutics in Head and Neck Squamous Cell Carcinoma
K. Devaraja
PHARMACEUTICAL MEDICINE (2019)
Glioblastoma Therapy in the Age of Molecular Medicine
Luiz Henrique Medeiros Geraldo et al.
TRENDS IN CANCER (2019)
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
Frederick M. Lang et al.
NEURO-ONCOLOGY (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
Gregory K. Friedman et al.
SCIENTIFIC REPORTS (2018)
A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy
Senthilkumar Kalimuthu et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
Ibrahim Ragab Eissa et al.
CANCERS (2018)
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Luke Russell et al.
NATURE COMMUNICATIONS (2018)
Oncolytic viruses as engineering platforms for combination immunotherapy
Kwame Twumasi-Boateng et al.
NATURE REVIEWS CANCER (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
Jana Portnow et al.
CLINICAL CANCER RESEARCH (2017)
The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence
Crystal A. Tonnessen-Murray et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Detection of sickness in conspecifics using olfactory and visual cues
Camille Ferdenzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
Wojciech K. Panek et al.
ONCOTARGET (2017)
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
Esther Rincon et al.
ONCOTARGET (2017)
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1-a phase I, first in human, first in class trial
Jobst C. von Einem et al.
ONCOTARGET (2017)
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
Yanni Zhu et al.
SCIENTIFIC REPORTS (2017)
Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
Sakhawat Ali et al.
JOURNAL OF CANCER (2017)
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
Christian Bressy et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson et al.
CLINICAL CANCER RESEARCH (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Targeting PI3K Signaling in Combination Cancer Therapy
Elvire Pons-Tostivint et al.
TRENDS IN CANCER (2017)
Use of genetically engineered stem cells for glioma therapy (Review)
Hiroki Namba et al.
ONCOLOGY LETTERS (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival
Antonella Mangraviti et al.
BIOMATERIALS (2016)
Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
Mehdi Najar et al.
CYTOTHERAPY (2016)
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma
Alexandra Pisklakova et al.
NEURO-ONCOLOGY (2016)
Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies
Kui Wang et al.
PHARMACOLOGICAL RESEARCH (2016)
The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells
Xing-Rong Guo et al.
ONCOTARGET (2016)
Human umbilical cord matrix-derived stem cells expressing interferon-β gene inhibit breast cancer cells via apoptosis
Ching-Ju Shen et al.
ONCOTARGET (2016)
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
Gila Kazimirsky et al.
STEM CELL RESEARCH & THERAPY (2016)
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Ann De Becker et al.
WORLD JOURNAL OF STEM CELLS (2016)
Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy
Jordi Martinez-Quintanilla et al.
MOLECULAR THERAPY (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
Shunlei Duan et al.
NATURE COMMUNICATIONS (2015)
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
Valerio Leoni et al.
ONCOTARGET (2015)
Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts
Simone Pacioni et al.
STEM CELL RESEARCH & THERAPY (2015)
Pre-Exposure of Human Adipose Mesenchymal Stem Cells to Soluble Factors Enhances Their Homing to Brain Cancer
Chris L. Smith et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil
Larissa A. Pikor et al.
TRENDS IN CANCER (2015)
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Giles W. Robinson et al.
BMC CANCER (2014)
Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
Gina Song et al.
CLINICAL CANCER RESEARCH (2014)
Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
Matthias Duebgen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Mesenchymal stem cells: immune evasive, not immune privileged
James A. Ankrum et al.
NATURE BIOTECHNOLOGY (2014)
A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells
Jingyan Jiang et al.
ONCOLOGY REPORTS (2014)
Recruited Brain Tumor-Derived Mesenchymal Stem Cells Contribute to Brain Tumor Progression
Jinan Behnan et al.
STEM CELLS (2014)
Preclinical Safety Assessment of Ad[I/PPT-E1A], a Novel Oncolytic Adenovirus for Prostate Cancer
Ellen Schenk et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
MicroRNAs in cancer biology and therapy: Current status and perspectives
Colles Price et al.
GENES & DISEASES (2014)
Stem cell-based therapy for malignant glioma
Daniel Bexell et al.
CANCER TREATMENT REVIEWS (2013)
Exosomes are natural carriers of exogenous siRNA to human cells in vitro
Tatyana A. Shtam et al.
CELL COMMUNICATION AND SIGNALING (2013)
Phase I Study of GRN1005 in Recurrent Malignant Glioma
Jan Drappatz et al.
CLINICAL CANCER RESEARCH (2013)
Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin
Kui Wang et al.
JOURNAL OF GENE MEDICINE (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
Mariella Gruber Filbin et al.
NATURE MEDICINE (2013)
TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo
Benny Perlstein et al.
NEURO-ONCOLOGY (2013)
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
Mikael Johansson et al.
NEURO-ONCOLOGY (2013)
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Thomas J. Kean et al.
STEM CELLS INTERNATIONAL (2013)
Mesenchymal stem cells engineered for cancer therapy
Khalid Shah
ADVANCED DRUG DELIVERY REVIEWS (2012)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model
B. Thaci et al.
CANCER GENE THERAPY (2012)
The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model
Song Fei et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect
Xin-Ran Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation
Murali Krishna Mamidi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Vitamin D3-Inducible Mesenchymal Stem Cell-Based Delivery of Conditionally Replicating Adenoviruses Effectively Targets Renal Cell Carcinoma and Inhibits Tumor Growth
Wan-Chi Hsiao et al.
MOLECULAR PHARMACEUTICS (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
Christopher A. Alvarez-Breckenridge et al.
NATURE MEDICINE (2012)
Immunomodulatory effect of mesenchymal stem cells on B cells
Marcella Franquesa et al.
FRONTIERS IN IMMUNOLOGY (2012)
CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas
Seong Muk Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma
V. Egea et al.
CELL DEATH AND DIFFERENTIATION (2011)
Genomic Profiles of Glioma
Cameron Brennan
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector
Yuhua Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Target gene therapy of glioma: overexpression of BAX gene under the control of both tissue-specific promoter and hypoxia-inducible element
Jiwei Huang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma
Peng Gao et al.
CANCER LETTERS (2010)
DC-Chol/DOPE cationic liposomes: A comparative study of the influence factors on plasmid pDNA and siRNA gene delivery
Yang Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Nobuyoshi Kosaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface
Irina V. Balyasnikova et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
Ann H. Klopp et al.
PLOS ONE (2010)
An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies
Carlos Almeida Ramos et al.
STEM CELLS (2010)
Oncogenes and Tumor Suppressor Genes
Eva Y. H. P. Lee et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling
Ling Qiao et al.
CANCER LETTERS (2008)
Stem and progenitor cell-mediated tumor selective gene therapy
K. S. Aboody et al.
GENE THERAPY (2008)
Cytotoxicity of nanoparticles
Nastassja Lewinski et al.
SMALL (2008)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases
Bo-Ra Son et al.
STEM CELLS (2006)
Gene therapy for malignant glioma: Current clinical status
KJ Pulkkanen et al.
MOLECULAR THERAPY (2005)
The p53 pathway: positive and negative feedback loops
SL Harris et al.
ONCOGENE (2005)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo et al.
CANCER RESEARCH (2005)
MDM2 is a central node in the p53 pathway: 12 years and counting
GL Bond et al.
CURRENT CANCER DRUG TARGETS (2005)
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
K Nakamura et al.
GENE THERAPY (2004)
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma:: Biological and clinical results
FF Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
